Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-04 · accession 0000950170-24-103998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-05 | 2024-09-04 | KPTI | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $0.72 | -5,356 | 404.1K | -1% | -$3,856 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-04 | S | D | 5,356 | $0.72 | 404,051 | D | — | — | (F2) Includes 15,898 shares acquired under the Karyopharm Therapeutics Inc. Amended & Restated 2013 Employee Stock Purchase Plan on April 30, 2024. |